Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06001853 · ClinicalTrials.gov registry record · Phase 2
Allogeneic BM-MSC's in Patients With Lumbar Facet Arthropathy
A Phase 2 study of Facet-Mediated Low Back Pain, sponsored by Mayo Clinic.
- Active
- Registry status
- Phase 2
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT06001853 is a Phase 2 study of Facet-Mediated Low Back Pain that is active but no longer recruiting, run by Mayo Clinic. The registered enrollment target is 40 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06001853, a Phase 2 study of Facet-Mediated Low Back Pain, is active but no longer recruiting, sponsored by Mayo Clinic.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 2
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to evaluate the safety and effect of bone marrow-derived stem cells for the treatment of low back pain.
Conditions Studied
Interventions
- DRUG BM-MSC injection
- DRUG DSMO Injection
Study Locations (1)
Florida
- Mayo Clinic in Florida - Jacksonville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2023-11-03 |
| Est. Completion | 2026-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06001853
The ClinicalTrials.gov registry entry for NCT06001853 describes a study currently listed as active not recruiting, categorized as Phase 2. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Facet-Mediated Low Back Pain appearing as the primary indexed condition, and to 2 interventions - of which BM-MSC injection is the first listed.
NCT06001853 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT06001853 about?
NCT06001853 is a clinical study titled "Allogeneic BM-MSC's in Patients With Lumbar Facet Arthropathy". The purpose of this research study is to evaluate the safety and effect of bone marrow-derived stem cells for the treatment of low back pain.
What is the current status of trial NCT06001853?
This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 40 participants. The study started on 2023-11-03. Estimated completion is 2026-07.
What conditions does trial NCT06001853 study?
This clinical trial studies the following conditions: Facet-Mediated Low Back Pain.
What interventions are being tested in trial NCT06001853?
The interventions under investigation include: BM-MSC injection (DRUG), DSMO Injection (DRUG).
Who is sponsoring clinical trial NCT06001853?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06001853 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Facet-Mediated Low Back Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.